Establishes an epinephrine auto-injector affordability program to provide low-cost epinephrine auto-injectors; requires insurance coverage for epinephrine auto-injectors and capping the co-pay or deductible for such at sixty dollars; makes failure to comply with the epinephrine auto-injectors affordability program a deceptive business practice; makes an appropriation therefor.